Small Cap Breakfast
Total number of AIM Companies (Incl Susp):
Total number of AIM Companies trading:
*as at close of business 26 May 2018
Standard List** of Main Market:
Total number of Standard List Companies
Total number of Standard List Companies trading:
*as at close of business 26 May 2018
NEX Growth Market:
Total number of NEX Growth Market Companies (Incl Susp):
Total number of NEX Growth Market Companies trading:
*as at close of business 26 May 2018
*A corporate client of Hybridan LLP
** Standard Listing as defined by Hybridan LLP to be a business with strictly operational activity
Dish of the day
No Joiners Today
Off the menu
Mandicon has left NEX Exchange
What’s cooking in the IPO kitchen?
Stratmin Global Resources RTO of Signature Gold a specialist Australian gold exploration company focused on the exploration and development of large-scale Intrusion Related Gold System. Offer TBA. Due 4 June. Will leave AIM under rule 41.
Block Energy— UK based oil exploration and production company whose main country of operation is the Republic of Georgia. Raising £4m. Mkt cap £9.3m. Due early June.
Codemasters Group— video game developer and publisher, specialising in high quality racing games. Offer TBA. Seeking £15m in primary. Due 1 June.
Strongbow Exploration (TSX:SBW) intends to dual list on AIM. Holds rights to the South Crofty underground tin mine, a former producing tin mine located in the towns of Pool and Camborne, Cornwall . The project is estimated to require the Company to raise £25 million over the next 18 months to progress to a production decision. Offer TBS. Due June.
Maestrano Group, a software company with operations in Australia (main country of operation), the UK, US and the UAE, is looking to join AIM. Cloud based automated management data system. Raising £6m at 15p. Mkt Cap £12m. Due 30 May.
Yew Grove REIT—newly formed Company will pursue its investment objective by investing in a diversified portfolio of Irish commercial property. Offer TBA. Due Late May
Main Market (Premium)
Utilico Global Income— new actively managed income investment trust raising up to £100 million . Due 22 June.
On the horizon (speculative and rumoured IPOs)
Press reports that Abu Dhabi's VPS Healthcare which operates about 20 hospitals and over 125 medical centers across the Middle East, Europe and India, is considering a London IPO.
Energiser Investments (LON:ENGI) 1.15p £1.4m
Final results. “During the year we sold the investment properties at Wellingborough for a consideration of £2.8m, the majority of the priority return from the Kingswood 12 unit development loan was also received in the year for a total of £773,000.”
Net assets have increased slightly to £1.77m (2016: £1.75m) following disposals and repayment of debt. This results in a net asset value per share at the year end of 1.43p (2016: 1.41p). Cash of £2m.
“The Group’s strategy is to invest in quoted and unquoted companies to achieve capital growth. Our focus is predominantly on investment opportunities within the real estate sector. In 2018 we will continue to actively manage our investments and uncover and transact in further accretive investment opportunities.”
AGM statement from the UK's largest property franchise. “Trading during the first four months of the current financial year has continued well and is in line with the Board's expectations”.
“Our franchisees, across all three brands, have completed on ten portfolio transactions under our Assisted Acquisitions programme adding £3.2m network revenue, nearly 2,500 managed properties and £0.3m p.a. of recurring Management Service Fees ("MSF"). The Group is seeing an unprecedented number of smaller independent lettings agents choosing to withdraw from the sector in the face of increased legislation and the previously announced ban on tenant fees, now expected in the Spring of 2019. As a result, there remains a strong pipeline of further opportunities to underpin the Group's growth target for 2018.” Pe c.9x. Yield > 6.5%.
“The LIGHT system has been designed to electronically control the fast delivery of protons to the tumour site. This unique ability provides the opportunity to alter the exact amount of radiation that is given to every part of the tumour in a few micro-seconds. This feature is invaluable for accurate tumour targeting and side-effect minimisation, particularly in the case of moving targets. As part of its testing and regulatory plan, the Company has developed a Time-of-Flight ("TOF") measurement system which measures the speed of the beam; this allows the system to measure the energy of each proton pulse, which is a very important clinical parameter.” “With much of the technological development now de-risked, the Company is on target to have a system capable of treating superficial tumours by the end of Q3 2018.”
Imaginatik (LON:IMTK) 1.1p £2.47m
“Update on funding and formal sale process
Imaginatik, the innovation company, today provides an update on its funding requirements.
Further to the Company's trading statement on 1 May 2018, the Company confirms that it is now exploring short term additional funding in order to successfully progress the ongoing formal sale process. As previously announced, the Board is aiming to announce the outcome of the process by the end of May.”
FYJan18 results from the provider of technology and services for smart buildings.
Revenue up 15% to £47.6m. Adjusted EBITDA up 60% to £3.2m. Net cash £1.2m.
Has also Announced the proposed sale of the Systems Integration and Managed Services divisions for a total consideration of £23m. “Following the disposal of the Managed Services and Systems Integration business the Group will reduce in size operationally. However, we plan to use the funds realised from the disposal to accelerate the growth of our Software business. This growth will initially be organic through the development of our direct and indirect sales channels, both in the UK and overseas. However, should we identify appropriate targets, we also plan to make acquisitions of businesses which either have a customer base that can be migrated onto our OneSpace platform or offer complementary technology that can add value to the OneSpace platform.”
Gaming Realms (LON:GMR) 8p £22.75m
“The developer, publisher and licensor of mobile real money and social games, is pleased to announce that it has signed a three-year licensing deal with Sony Pictures Television (SPT). The deal will see Gaming Realms create and host the new gaming website millionairegames.com on its proprietary platform following the successful return of 'Who Wants To Be A Millionaire?' in the United Kingdom.
The new millionairegames.com site went live in tandem with the return of 'Who Wants To Be A Millionaire?' on ITV, marking the 20th anniversary of SPT's hit global game show. The deal will also see the creation and launch of a Slingo game format of 'Who Wants To Be A Millionaire?' later this summer.”
The “high technology designer and manufacturer of LED illumination systems and laser diode modules, with operations in Ireland and the UK, announces it has delivered a three-meter-long RGB LED line light [perhaps the largest of its kind] to a world class inkjet printer manufacturer. The modular COBRA RGB offers superior brightness, excellent colour tuning capability, and fast switching speeds. This 3m COBRA RGB provides extremely bright, uniform, multispectral illumination ideally suited in line scan applications such as print inspection and calibration.”
“This project demonstrates how our products can be configured to deliver the ideal solution to a customer's specific use case without having to consider a customized solution."
Medaphor Group (LON:MED) 11.25p £10.2m
The intelligent ultrasound software and simulation company, “has installed its first BodyWorks Eve, Point of Care ultrasound (PoCUS) simulator, at NYU School of Medicine, in the simulation laboratory of the affiliated Veterans Affairs New York Harbor Healthcare System NY Campus, New York, USA.
BodyWorks Eve is an ultra-realistic female manikin-based simulator designed specifically for doctors looking to train in PoCUS and will aid the teaching of PoCUS to medical students, residents and faculty. Complete with over 100 real patient scans and over 10,000 pathology variations across cardiac, lung, transabdominal and pelvic ultrasound, it is the most dynamic simulator available for ultrasound scenario training with structured educational content, based on the International Federation of Emergency Medicine (IFEM) PoCUS curriculum guidelines.”
ImmuPharma (LON:IMM) 27.6p £38.49m
The specialist drug discovery and development company, announced further analysis of the results from its pivotal Phase III trial of Lupuzor™, its lead programme for the potential breakthrough compound for Lupus. This new data follows the top-line trial results published on 17 April 2018 and which may create new commercial value for Lupuzor™. As previously announced, across the whole study population, in those patients who had anti-dsDNA autoantibodies, Lupuzor™ demonstrated a superior response rate over placebo (61.5% vs 47.3%, p=0.0967), although these results were not statistically significant. Further data however showed statistically significant results in the European cohort.
ImmuPharma will discuss these findings with its regulatory, scientific and medical experts in order to formulate discussions with the regulatory agencies on next steps. In parallel, the Company will also continue to progress discussions with potential corporate partners.
“Altus Strategies Plc (AIM:ALS), the Africa focused exploration project generator, announces that its 100% owned subsidiary Aterian Resource Ltd has been granted new exploration licences, targeting zinc and copper in Morocco.
Ammas, Takzim Est and Arfa licences granted totalling 87.55 km2 in Morocco
Ammas licence located 3km along strike of Hajjar VMS zinc-copper mine
Takzim Est licence located 6km east of the Company's Takzim zinc project
Arfa licence located in the Oriental province of north-eastern Morocco
Discovery of quartz stockworks and gossanous outcrops at Ammas”.